Experimental Biology and Medicine

Neuroscience

A novel biomarker for multiple sclerosis

An article published in Experimental Biology and Medicine (Volume 242, Issue 15, September, 2017) identifies opioid growth factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS). The study, ...

Oncology & Cancer

A plant-based delivery system for anti-cancer drugs

An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August, 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs. The study, led by Dr. Nicole Steinmetz in the ...

Oncology & Cancer

Targeting cancer cells with an implantable drug delivery system

An article published in Experimental Biology and Medicine (Volume 242, Issue 7, March, 2017) describes a new drug delivery system for the treatment of cancer. The study, led by Dr. Horst A. von Recum from the Department of ...

Oncology & Cancer

Suppressing vasculogenic mimicry in breast cancer

An article published in Experimental Biology and Medicine (Volume 242, Issue 6, March, 2017) identifies a new signaling pathway involved in breast cancer cell growth. The study, led by Dr. Chan-Wha Kim, from the Department ...

Genetics

Researchers find potential treatments for hemoglobinopathies

An article published in Experimental Biology and Medicine (Volume 242, Issue 3, February, 2017) identifies microRNAs (miRNAs) as key factors in some hemoglobinopathies, genetic disorders characterized by alterations in the ...

Medical research

Nuclear export of opioid growth factor receptor is CRM1 dependent

In a study in the February 2016 Issue (241:3) of Experimental Biology and Medicine researchers at The Pennsylvania State University College of Medicine, led by Dr. Pat McLaughlin, discovered that a novel biological pathway, ...

page 3 from 7